Ultra-wide field imaging in the screening of diabetic retinopathy

Despite recent advancements in care, diabetic retinopathy (DR) remains an important cause of blindness (1,2). Screening of DR has been introduced as part of the health care systems in various countries (3-5), and, consequently, recent data from UK have demonstrated that DR is no longer the leading cause of blindness in the working-age population (6).